| Name | Title | Contact Details |
|---|
We`re FinThrive and we believe revenue management technology will drive the future of healthcare. We pave the way for a healthcare system that ensures every transaction and patient experience is addressed holistically. FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we`re advancing the healthcare economy.
SCA Health is a company that specializes in providing specialty care services to patients across America. They support physician specialists, care for patients, and welcome new partners to their family of businesses.
ForeSee Health is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
Airport Health Club is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Airport Health Club is based in Santa Rosa, CA. You can find more information on Airport Health Club at www.airportclub.com